Transcutaneous Suboccipital Neurostimulation for the Treatment of Chronic Migraine
Transcutaneous Suboccipital Neurostimulation for the Treatment of Chronic Migraine
This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.
Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population.
CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years.
The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.
Inclusion Criteria:
Exclusion Criteria:
cossedduanna@gmail.com+3242256925